Patents Assigned to ORAMED LTD.
  • Publication number: 20210369626
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: February 1, 2021
    Publication date: December 2, 2021
    Applicant: Oramed Ltd.
    Inventors: Avraham HERSHKO, Miriam KIDRON
  • Publication number: 20210113663
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 22, 2021
    Applicant: Oramed Ltd.
    Inventor: Miriam KIDRON
  • Patent number: 10967051
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: April 6, 2021
    Assignee: Oramed Ltd.
    Inventors: Miriam Kidron, Ehud Arbit
  • Publication number: 20210077588
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: March 23, 2020
    Publication date: March 18, 2021
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Patent number: 10933022
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: March 2, 2021
    Assignee: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Patent number: 10881714
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: January 5, 2021
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Publication number: 20190374615
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 12, 2019
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Publication number: 20190321303
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 24, 2019
    Applicant: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Publication number: 20190314275
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: June 10, 2019
    Publication date: October 17, 2019
    Applicant: Oramed Ltd.
    Inventor: Miriam Kidron
  • Patent number: 10398762
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analog.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: September 3, 2019
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Patent number: 10350162
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: July 16, 2019
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Publication number: 20190209655
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: November 19, 2018
    Publication date: July 11, 2019
    Applicant: ORAMED LTD.
    Inventors: Miriam Kidron, Ehud Arbit
  • Patent number: 10342764
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: July 9, 2019
    Assignee: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Publication number: 20180369339
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: July 27, 2018
    Publication date: December 27, 2018
    Applicant: Oramed Ltd.
    Inventor: Miriam Kidron
  • Patent number: 10058593
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: August 28, 2018
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Publication number: 20150017238
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: January 3, 2013
    Publication date: January 15, 2015
    Applicant: Oramed, Ltd.
    Inventor: Miriam Kidron
  • Publication number: 20130195939
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: April 2, 2013
    Publication date: August 1, 2013
    Applicant: Oramed Ltd.
    Inventor: Oramed Ltd.
  • Publication number: 20110142800
    Abstract: This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, methods for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
    Type: Application
    Filed: August 11, 2009
    Publication date: June 16, 2011
    Applicant: Oramed Ltd.
    Inventors: Miriam Kidron, Ehud Arbit
  • Publication number: 20110046053
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: May 3, 2009
    Publication date: February 24, 2011
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Publication number: 20110014247
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: February 26, 2009
    Publication date: January 20, 2011
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron